First Trust NYSE Arca Biotechnology Index Fund
FBTNYSEARCAFirst TrustEquity
As of Oct 23, 2026 close
- Assets (AUM)
- $2.99B
- Expense ratio
- 0.55%
- Dividend yield
- -
- Holdings
- 33
- 52-week range
- $186.20$275.23
- Volume (live)
- -
- Avg. volume (3M)
- 80.73K
FBT ETF: First Trust NYSE Arca Biotechnology Index Fund - Price, Holdings & Analysis
First Trust NYSE Arca Biotechnology Index Fund Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $269.80 - $269.80 |
|---|---|
| 52-Week High | $275.23 |
| 52-Week Low | $186.20 |
| Open | $269.80 |
| Volume (last close) | 60.23K |
| Average Volume (3M) | 80.73K |
| 1 Day Change | +0.08% |
|---|---|
| 1 Month Change | +1.29% |
| 6 Month Change | +33.61% |
| YTD Change | +31.27% |
| 1 Year Change | +44.00% |
| 5 Year Change | +66.21% |
| 10 Year Change | +201.57% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Dec 13, 2024 |
| Dividend Growth YoY | −100.00% |
| Assets (AUM) | $2.99B |
|---|---|
| Expense Ratio | 0.55% |
| Total Holdings | 33 |
| Inception Date | Jun 18, 2006 |
| 50-Day MA | $266.90 |
|---|---|
| 200-Day MA | $230.54 |
| RSI | 56.23 |
| Stochastic %K | 91.03 |
| Stochastic %D | 60.26 |
Source: Exchange price data and fund disclosures. Data as of Oct 23, 2026. Data sources and methodology
FBT at a Glance
First Trust NYSE Arca Biotechnology Index Fund (FBT) is an equity ETF from First Trust, launched in June 2006. It manages $2.99B in assets and charges a 0.55% expense ratio, about $55 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 33 positions. The largest are Natera, Inc. (NTRA, 4.74%), Halozyme Therapeutics, Inc. (HALO, 4.49%) and Illumina, Inc. (ILMN, 4.47%). The top 10 holdings make up 40.6% of the fund. By sector it leans toward Healthcare (100.0%). 96.9% of assets are in the United States.
It does not currently pay distributions. As of the Oct 23, 2026 close, the share price is up 44.0% over one year, up 66.2% over five years and up 201.6% over ten years (price change, excluding distributions).
Frequently Asked Questions About First Trust NYSE Arca Biotechnology Index Fund
What is the current price of FBT?
The latest FBT price is $269.25 (Oct 23, 2026 close). The 52-week range is $186.20–$275.23. The share price is up 44.0% over the past year (price change, excluding distributions).
What is the expense ratio for FBT?
FBT's annual expense ratio is 0.55%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does FBT pay dividends?
First Trust NYSE Arca Biotechnology Index Fund does not currently pay dividends. Check the ETF Screener for dividend-focused alternatives in the Equity category.
What are the top holdings of FBT?
As of Oct 4, 2026, FBT's largest holdings are Natera, Inc. (4.7%), Halozyme Therapeutics, Inc. (4.5%), Illumina, Inc. (4.5%) (combined weight: 13.7%). The fund holds 33 total positions. View the complete portfolio breakdown in the Holdings section.
How does FBT compare to similar ETFs?
Compare FBT (0.55% expense ratio, $2.99B AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.